Optimizing glycan shield coverage, germline B cell receptor targeting and epitope diversity of V2-apex targeted HIV-1 Env immunogens
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
University of Pennsylvania
Start Date
September 1, 2024
End Date
August 31, 2025
Administered By
Duke Human Vaccine Institute
Awarded By
University of Pennsylvania
Start Date
September 1, 2024
End Date
August 31, 2025